Literature DB >> 32624460

Angiographic predictors of outcome in myocardial infarction patients presenting with cardiogenic shock: a CULPRIT-SHOCK angiographic substudy.

Pavel Overtchouk1, Olvier Barthélémy, Marie Hauguel-Moreau, Paul Guedeney, Stéphanie Rouanet, Michel Zeitouni, Johanne Silvain, Jean-Philippe Collet, Eric Vicaut, Uwe Zeymer, Steffen Desch, Holger Thiele, Gilles Montalescot.   

Abstract

AIMS: The aim of this study was to determine the prognostic impact of pre- and post-PCI TIMI flow grade and TIMI myocardial perfusion grade (TMPG) in a well-defined group of patients with cardiogenic shock due to acute myocardial infarction. METHODS AND
RESULTS: Patients with infarct-related cardiogenic shock randomised into the CULPRIT-SHOCK trial were included in the angiographic predictor analysis whenever their TIMI flow grade or TMPG was available in the core lab database (96.9% of cases). A multivariable logistic regression analysis, adjusted on non-angiographic covariates, was performed to investigate whether TIMI flow grade or TMPG was independently associated with all-cause mortality or renal replacement therapy up to one year. Pre-PCI TIMI flow grade and TMPG did not impact on mortality. When analysed in separate multivariable models, post-PCI TIMI 3 flow and TMPG grade 3 were both significantly associated with reduced risk of 30-day mortality: aOR 0.61 (95% CI: 0.38-0.97, p=0.037) and 0.46 (95% CI: 0.29-0.72, p<0.001), respectively. When considered in the same multivariable model, only TMPG was significantly associated with 30-day mortality (aOR 0.38 [0.20-0.71], p=0.002), the 30-day composite of all-cause mortality and renal replacement therapy (aOR 0.34 [0.18-0.66], p=0.001) and mortality at one-year follow-up (aOR 0.46 [0.24-0.88], p=0.02).
CONCLUSIONS: Post-PCI TIMI flow grade and TMPG are associated with mortality after PCI. TMPG is a better discriminator, supporting microcirculation rather than epicardial reperfusion for prognosis estimation.

Entities:  

Mesh:

Year:  2021        PMID: 32624460     DOI: 10.4244/EIJ-D-20-00139

Source DB:  PubMed          Journal:  EuroIntervention        ISSN: 1774-024X            Impact factor:   6.534


  2 in total

1.  Non-STEMI vs. STEMI Cardiogenic Shock: Clinical Profile and Long-Term Outcomes.

Authors:  María José Martínez; Ferran Rueda; Carlos Labata; Teresa Oliveras; Santiago Montero; Marc Ferrer; Nabil El Ouaddi; Jordi Serra; Josep Lupón; Antoni Bayés-Genís; Cosme García-García
Journal:  J Clin Med       Date:  2022-06-20       Impact factor: 4.964

2.  Association of C-Reactive Protein Velocity with Early Left Ventricular Dysfunction in Patients with First ST-Elevation Myocardial Infarction.

Authors:  Magdalena Holzknecht; Christina Tiller; Martin Reindl; Ivan Lechner; Priscilla Fink; Patrick Lunger; Agnes Mayr; Benjamin Henninger; Christoph Brenner; Gert Klug; Axel Bauer; Bernhard Metzler; Sebastian Johannes Reinstadler
Journal:  J Clin Med       Date:  2021-11-24       Impact factor: 4.241

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.